- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 1/04 - Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Patent holdings for IPC class A61P 1/04
Total number of patents in this class: 3425
10-year publication summary
|
84
|
99
|
142
|
209
|
212
|
248
|
204
|
226
|
225
|
193
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2717 |
69 |
| Daiichi Sankyo Company, Limited | 1877 |
53 |
| AstraZeneca AB | 2858 |
48 |
| Osaka University | 3382 |
28 |
| Janssen Biotech, Inc. | 1590 |
24 |
| The Regents of the University of California | 20289 |
22 |
| Ono Pharmaceutical Co., Ltd. | 428 |
22 |
| Raqualia Pharma Inc. | 122 |
21 |
| Dainippon Sumitomo Pharma Co., Ltd. | 178 |
19 |
| Meiji Co., Ltd. | 736 |
19 |
| Taisho Pharmaceutical Co., Ltd. | 860 |
19 |
| Eisai R&D Management Co., Ltd. | 1202 |
19 |
| Astellas Pharma Inc. | 1057 |
18 |
| Cedars-Sinai Medical Center | 1176 |
18 |
| The University of Tokyo | 4249 |
18 |
| Ajinomoto Co., Inc. | 2310 |
17 |
| Nippon Shinyaku Co., Ltd. | 324 |
17 |
| Daewoong Pharmaceutical Co., Ltd. | 323 |
16 |
| Prometheus BioSciences, Inc. | 86 |
15 |
| Chugai Seiyaku Kabushiki Kaisha | 1378 |
14 |
| Other owners | 2929 |